Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.

Ma H, Xu X, Ursin G, Simon MS, Marchbanks PA, Malone KE, Lu Y, McDonald JA, Folger SG, Weiss LK, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L.

Cancer Med. 2015 Jul;4(7):1122-35. doi: 10.1002/cam4.465. Epub 2015 Apr 27.

2.

Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.

Ma H, Lu Y, Marchbanks PA, Folger SG, Strom BL, McDonald JA, Simon MS, Weiss LK, Malone KE, Burkman RT, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L.

Breast Cancer Res. 2013;15(5):R90.

3.

Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L, Spirtas R, McDonald JA, Strom BL, Burkman RT, Simon MS, Liff JM, Daling JR, Malone KE.

Cancer Causes Control. 2012 May;23(5):671-81. doi: 10.1007/s10552-012-9925-x. Epub 2012 Mar 15.

4.

Oral contraceptive formulation and risk of breast cancer.

Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R.

Contraception. 2012 Apr;85(4):342-50. doi: 10.1016/j.contraception.2011.08.007. Epub 2011 Sep 28.

5.

Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

Press DJ, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL, Norman SA, Simon MS, Marchbanks PA, Folger SG, Liff JM, Burkman RT, Malone KE, Weiss LK, Spirtas R, Bernstein L.

Am J Epidemiol. 2011 Jan 1;173(1):38-47. doi: 10.1093/aje/kwq339. Epub 2010 Nov 25.

6.

A case-control study of body mass index and breast cancer risk in white and African-American women.

Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, Weiss LK, Liff JM, McDonald JA, Strom BL, Simon MS, Deapen D, Press MF, Burkman RT, Spirtas R, Ursin G.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1532-44. doi: 10.1158/1055-9965.EPI-10-0025. Epub 2010 May 25.

7.

Hormone therapy and fatal breast cancer.

Norman SA, Weber AL, Localio AR, Marchbanks PA, Ursin G, Strom BL, Weiss LK, Burkman RT, Bernstein L, Deapen DM, Folger SG, Simon MS, Nadel MR.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):440-7. doi: 10.1002/pds.1941.

8.

Protection of mammography screening against death from breast cancer in women aged 40-64 years.

Norman SA, Russell Localio A, Weber AL, Coates RJ, Zhou L, Bernstein L, Malone KE, Marchbanks PA, Weiss LK, Lee NC, Nadel MR.

Cancer Causes Control. 2007 Nov;18(9):909-18. Epub 2007 Jul 31.

PMID:
17665313
9.

Risk of breast cancer associated with short-term use of oral contraceptives.

Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, Daling JR, Norman SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Malone KE, Spirtas R.

Cancer Causes Control. 2007 Mar;18(2):189-98. Epub 2007 Jan 10.

PMID:
17216547
10.

Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.

Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, Marchbanks PA, Simon MS, McDonald JA, Norman SA, Strom BL, Burkman RT, Ursin G, Deapen D, Weiss LK, Folger S, Madeoy JJ, Friedrichsen DM, Suter NM, Humphrey MC, Spirtas R, Ostrander EA.

Cancer Res. 2006 Aug 15;66(16):8297-308.

11.

Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study.

Simon MS, Korczak JF, Yee CL, Malone KE, Ursin G, Bernstein L, McDonald JA, Deapen D, Strom BL, Press MF, Marchbanks PA, Burkman RT, Weiss LK, Schwartz AG.

J Clin Oncol. 2006 Jun 1;24(16):2498-504.

PMID:
16735703
12.

Body size and risk of epithelial ovarian cancer (United States).

Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG, Weiss NS.

Cancer Causes Control. 2006 Jun;17(5):713-20.

PMID:
16633919
13.

A population-based study of the quality of life of cancer survivors and their family caregivers.

Mellon S, Northouse LL, Weiss LK.

Cancer Nurs. 2006 Mar-Apr;29(2):120-31; quiz 132-3.

PMID:
16565621
14.

Lifetime recreational exercise activity and breast cancer risk among black women and white women.

Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, Daling JR, McDonald JA, Norman SA, Malone KE, Strom BL, Liff J, Folger SG, Simon MS, Burkman RT, Marchbanks PA, Weiss LK, Spirtas R.

J Natl Cancer Inst. 2005 Nov 16;97(22):1671-9.

PMID:
16288120
15.

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology.

Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R.

Br J Cancer. 2005 Aug 8;93(3):364-71.

16.

Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences study.

McDonald JA, Mandel MG, Marchbanks PA, Folger SG, Daling JR, Ursin G, Simon MS, Bernstein L, Strom BL, Norman SA, Malone KE, Weiss LK, Burkman RT, Weber AL, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2106-16.

17.

A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.

Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG.

Am J Epidemiol. 2004 Dec 1;160(11):1070-8.

PMID:
15561986
18.

Reproductive factors and risk of breast carcinoma in a study of white and African-American women.

Ursin G, Bernstein L, Wang Y, Lord SJ, Deapen D, Liff JM, Norman SA, Weiss LK, Daling JR, Marchbanks PA, Malone KE, Folger SG, McDonald JA, Burkman RT, Simon MS, Strom BL, Spirtas R.

Cancer. 2004 Jul 15;101(2):353-62.

19.

Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.

Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R.

Contraception. 2004 May;69(5):353-60.

PMID:
15105056
20.

Cancer among Arab Americans in the metropolitan Detroit area.

Schwartz KL, Kulwicki A, Weiss LK, Fakhouri H, Sakr W, Kau G, Severson RK.

Ethn Dis. 2004 Winter;14(1):141-6.

PMID:
15002934
21.

Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.

Norman SA, Berlin JA, Weber AL, Strom BL, Daling JR, Weiss LK, Marchbanks PA, Bernstein L, Voigt LF, McDonald JA, Ursin G, Liff JM, Burkman RT, Malone KE, Simon MS, Folger SG, Deapen D, Wingo PA, Spirtas R.

Cancer Causes Control. 2003 Dec;14(10):933-43.

PMID:
14750532
22.

Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1175-81.

23.

Validation of self-reported screening mammography histories among women with and without breast cancer.

Norman SA, Localio AR, Zhou L, Bernstein L, Coates RJ, Flagg EW, Marchbanks PA, Malone KE, Weiss LK, Lee NC, Nadel MR.

Am J Epidemiol. 2003 Aug 1;158(3):264-71.

PMID:
12882949
24.

Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study.

Burkman RT, Tang MT, Malone KE, Marchbanks PA, McDonald JA, Folger SG, Norman SA, Strom BL, Bernstein L, Ursin G, Weiss LK, Daling JR, Simon MS, Spirtas R.

Fertil Steril. 2003 Apr;79(4):844-51.

PMID:
12749419
25.

Hormone replacement therapy regimens and breast cancer risk(1).

Weiss LK, Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR, Norman SA, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Berlin JA, Weber AL, Doody DR, Wingo PA, McDonald JA, Malone KE, Folger SG, Spirtas R.

Obstet Gynecol. 2002 Dec;100(6):1148-58.

PMID:
12468157
26.

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R.

Cancer. 2002 Dec 15;95(12):2455-64.

27.

Oral contraceptives and the risk of breast cancer.

Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK.

N Engl J Med. 2002 Jun 27;346(26):2025-32.

28.

The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results.

Marchbanks PA, Mcdonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, Malone KE, Strom BL, Norman SA, Weiss LK, Liff JM, Wingo PA, Burkman RT, Folger SG, Berlin JA, Deapen DM, Ursin G, Coates RJ, Simon MS, Press MF, Spirtas R.

Ann Epidemiol. 2002 May;12(4):213-21.

PMID:
11988408
29.

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality.

Demers RY, Tiwari A, Wei J, Weiss LK, Severson RK, Montie J.

Cancer. 2001 Nov 1;92(9):2309-17.

PMID:
11745285
30.

Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.

Gadgeel SM, Severson RK, Kau Y, Graff J, Weiss LK, Kalemkerian GP.

Chest. 2001 Jul;120(1):55-63.

PMID:
11451816
31.

Axillary lymph node metastases associated with small invasive breast carcinomas.

Maibenco DC, Weiss LK, Pawlish KS, Severson RK.

Cancer. 1999 Apr 1;85(7):1530-6.

PMID:
10193943
32.

Issues in comparing survival rates for Detroit and Toronto.

Weiss LK, Severson RK, Swanson GM.

Am J Public Health. 1998 Oct;88(10):1556-7. No abstract available.

33.

Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults.

Severson RK, Schenk M, Gurney JG, Weiss LK, Demers RY.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):81-4.

34.

Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area.

Demers RY, Swanson GM, Weiss LK, Kau TY.

Arch Intern Med. 1994 Jun 13;154(11):1211-6.

PMID:
8203988
35.

Trends in cervical cancer incidence among young black and white women in metropolitan Detroit.

Weiss LK, Kau TY, Sparks BT, Swanson GM.

Cancer. 1994 Apr 1;73(7):1849-54.

PMID:
8137209

Supplemental Content

Loading ...
Support Center